Meidensha Corporation (TSE:6508) shareholders are probably feeling a little disappointed, since its shares fell 8.5% to JP¥6,887 in the week after its latest interim results. It was a credible result overall, with revenues of JP¥154b and statutory earnings per share of JP¥78.50 both in line with analyst estimates, showing that Meidensha is executing in line with expectations. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. We thought readers would find it interesting to see the analysts latest (statutory) post-earnings forecasts for next year.
Taking into account the latest results, the consensus forecast from Meidensha's six analysts is for revenues of JP¥373.0b in 2027. This reflects an okay 6.9% improvement in revenue compared to the last 12 months. Statutory earnings per share are expected to shrink 6.2% to JP¥625 in the same period. In the lead-up to this report, the analysts had been modelling revenues of JP¥371.0b and earnings per share (EPS) of JP¥619 in 2027. The consensus analysts don't seem to have seen anything in these results that would have changed their view on the business, given there's been no major change to their estimates.
View our latest analysis for Meidensha
With the analysts reconfirming their revenue and earnings forecasts, it's surprising to see that the price target rose 15% to JP¥12,820. It looks as though they previously had some doubts over whether the business would live up to their expectations. Fixating on a single price target can be unwise though, since the consensus target is effectively the average of analyst price targets. As a result, some investors like to look at the range of estimates to see if there are any diverging opinions on the company's valuation. The most optimistic Meidensha analyst has a price target of JP¥14,000 per share, while the most pessimistic values it at JP¥11,000. Even so, with a relatively close grouping of estimates, it looks like the analysts are quite confident in their valuations, suggesting Meidensha is an easy business to forecast or the the analysts are all using similar assumptions.
One way to get more context on these forecasts is to look at how they compare to both past performance, and how other companies in the same industry are performing. It's clear from the latest estimates that Meidensha's rate of growth is expected to accelerate meaningfully, with the forecast 14% annualised revenue growth to the end of 2027 noticeably faster than its historical growth of 6.3% p.a. over the past five years. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to grow their revenue at 6.5% per year. Factoring in the forecast acceleration in revenue, it's pretty clear that Meidensha is expected to grow much faster than its industry.
The most important thing to take away is that there's been no major change in sentiment, with the analysts reconfirming that the business is performing in line with their previous earnings per share estimates. Fortunately, they also reconfirmed their revenue numbers, suggesting that it's tracking in line with expectations. Additionally, our data suggests that revenue is expected to grow faster than the wider industry. There was also a nice increase in the price target, with the analysts clearly feeling that the intrinsic value of the business is improving.
Keeping that in mind, we still think that the longer term trajectory of the business is much more important for investors to consider. We have estimates - from multiple Meidensha analysts - going out to 2029, and you can see them free on our platform here.
We don't want to rain on the parade too much, but we did also find 2 warning signs for Meidensha (1 is significant!) that you need to be mindful of.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.